Skip to content
value.today

Pearl Therapeutics Inc

🇺🇸 Redwood City, California, USAPharmaceuticalsFounded 2006
Total raised
$74 M
3 rounds on record
Latest round
$23 M
Oct 2012
First round on record
Oct 2010
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pearl Therapeutics Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2012$23 MNo. 3$10 to $50 million

Pearl Therapeutics Inc: Raise no. 3, Oct 2012

Investors in this round

6 investors had bought by the notice of Nov 14, 2012: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $66 M offered; $43 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chadwick Orevillo · Executive Officer
  • Charles Bramlage · Executive Officer, Director
  • Colin Reisner · Executive Officer
  • Michael Golden · Executive Officer
  • Sarvajna Dwivedi · Executive Officer
  • William Picht, Jr. · Executive Officer
  • Howard B. Rosen · Director
  • James B. Niedel · Director
  • James W. Young · Director
  • Kevin B. Ferro · Director
  • Nicholas J. Simon · Director
  • Steven B. Jaharis · Director
  • Sundar Kodiyalam · Director
  • Thomas B. Koestler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark V. Roeder, Secretary. Newest notice filed Nov 14, 2012. Read the notice at the SEC.

equity, optionsSEC
Jun 2012$13 MNo. 2$10 to $50 million

Pearl Therapeutics Inc: Raise no. 2, Jun 2012

Investors in this round

6 investors had bought by the notice of Nov 14, 2012: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $14 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chadwick Orevillo · Executive Officer
  • Charles Bramlage · Executive Officer, Director
  • Colin Reisner · Executive Officer
  • Michael Golden · Executive Officer
  • Sarvajna Dwivedi · Executive Officer
  • William Picht, Jr. · Executive Officer
  • Howard B. Rosen · Director
  • James B. Niedel · Director
  • James W. Young · Director
  • Kevin B. Ferro · Director
  • Nicholas J. Simon · Director
  • Steven B. Jaharis · Director
  • Sundar Kodiyalam · Director
  • Thomas B. Koestler · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark V. Roeder, Secretary. Newest notice filed Nov 14, 2012. Read the notice at the SEC.

debt, optionsSEC
Oct 2010$37 MNo. 1$10 to $50 million

Pearl Therapeutics Inc: Raise no. 1, Oct 2010

Investors in this round

6 investors had bought by the notice of Nov 18, 2010: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $70 M offered; $32 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chadwick Orevillo · Executive Officer
  • Colin Reisner · Executive Officer
  • Howard Rosen · Executive Officer, Director
  • Michael Golden · Executive Officer
  • Sarvajna Dwivedi · Executive Officer
  • William Picht, Jr. · Executive Officer
  • James Young · Director
  • Kathy Laporte · Director
  • Nicholas Simon · Director
  • Sundar Kodijalam · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark V. Roeder, Secretary. Newest notice filed Nov 18, 2010. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pearl Therapeutics Inc chose not to state its revenue in its newest notice of a funding round (Nov 2012).

    SEC Form D · Nov 2012

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Nov 2012

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pearl Therapeutics Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pearl Therapeutics Inc
NameRoleNamed in
Chadwick OrevilloExecutive officerNov 2012
Charles BramlageExecutive officerNov 2012
Colin ReisnerExecutive officerNov 2012
Michael GoldenExecutive officerNov 2012
Sarvajna DwivediExecutive officerNov 2012
William Picht, Jr.Executive officerNov 2012
Howard RosenExecutive officerNov 2010
Charles BramlageDirectorNov 2012
Howard B. RosenDirectorNov 2012
James B. NiedelDirectorNov 2012
James W. YoungDirectorNov 2012
Kevin B. FerroDirectorNov 2012
Nicholas J. SimonDirectorNov 2012
Steven B. JaharisDirectorNov 2012
Sundar KodiyalamDirectorNov 2012
Thomas B. KoestlerDirectorNov 2012
Howard RosenDirectorNov 2010
James YoungDirectorNov 2010
Kathy LaporteDirectorNov 2010
Nicholas SimonDirectorNov 2010
Sundar KodijalamDirectorNov 2010